Lobe Sciences Ltd.
LOBEF
Rank in Stocks
#29150
Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the... Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the exploration and advancement of psychedelic pharmaceutical compounds. The company is actively engaged in formulating psilocybin-derived therapeutics, combined with N-acetylcysteine, intended for the treatment of mild traumatic brain injuries and post-traumatic stress disorder. Beyond drug development, it also engineers specialized devices designed to facilitate the efficient delivery of various medications. The organization was previously known as Greenstar Biosciences Corp. before formally changing its name to Lobe Sciences Ltd. in November 2020. Its main corporate office is situated in Vancouver, Canada.
Share Price
$0.0287
Last synced: 2026-11-09
Market Cap
$8.73M
Change (1 day)
7.49%
Change (1 year)
-18.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lobe Sciences Ltd. (LOBEF)
Category
Healthcare
Operating Margin for Lobe Sciences Ltd. (LOBEF)
Operating Margin as of November 2026 TTM: 0.00%
According to Lobe Sciences Ltd.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Lobe Sciences Ltd. from 2011 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -1,553.54% | 288.74% |
| 2023 | -399.63% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -306.05% | -17.37% |
| 2019 | -370.38% | 1,320.17% |
| 2018 | -26.08% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | - |
DE
|
|
| 19.68% | - |
DE
|
|
| 13.26% | - |
JP
|
|
| 17.08% | - |
CH
|
|
| 14.92% | - |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Lobe Sciences Ltd.'s operating margin
What was Lobe Sciences Ltd.'s operating margin in 2025?
In 2025, Lobe Sciences Ltd.'s operating margin was 0.00%, compared with -1,553.54% in 2024.
How has Lobe Sciences Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Lobe Sciences Ltd.'s operating margin was highest in 2025 (0.00%) and lowest in 2024 (-1,553.54%).
How does Lobe Sciences Ltd.'s operating margin compare with similar companies?
Lobe Sciences Ltd.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.